Navigation Links
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Date:7/29/2010

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to (i) ANA598's initial SVR12 profile based on the results from the six patients in this first group; (ii) the potential for HCV patients to be successfully treated with shortened courses of treatment, reflecting the continuing benefit of ANA598 post-therapy; (iii) the belief that ANA598 is one of the most attractive agents in Phase II HCV development today; (iv) the expected timing for post-treatment results from the other dose groups; and (v) the ability for patients to achieve an SVR in the Phase II combination study.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues or will continue to have favorable results as the Phase II trial progresses. In addition, Anadys' results may be affected by competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, includ
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015 Today, UBM China, a ... agreement with Chengdu Tianyi Exhibition Co., Ltd. to jointly ... is to be held concurrently with CWMEE 2016. ... healthcare exhibition family, following MEDTEC China and DENTECH China, ... in west China. It,s also another concrete cooperative project ...
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... PARK, N.C. , June 30, 2015  Marken, ... services to the life sciences industry, has been granted ... to patient shipment of clinical drug product in Korea.  ... South Korea to continue receiving their ... Respiratory System (MERS). The emergency was caused ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Congressmen Joe Kennedy III (D-MA) and Danny Davis (D-IL) for writing to the ... its investigation into the nation’s largest behavioral healthcare system, Universal Health Services (UHS).[1] ...
(Date:6/30/2015)... , ... June 30, 2015 , ... India Network ... of Aetna, Inc. for its visitor health insurance plans that provides coverage for visitors ... of providers nationwide to enable visitors to obtain services from most experienced health care ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... that Ellen D. Wagner, Chief Research and Strategy Officer at Predictive Analytics Reporting ... at the National Science Foundation (NSF), will provide keynote addresses at the 2015 ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... advanced protection at less thickness than any other padding in football. , Developed ... protection and shock absorption, Gameday Armour is engineered with D3O protective polymer. This ...
(Date:6/30/2015)... ... ... Amerec, a division of TyloHelo Inc, is pleased to announce the sauna ... by the Interior Design Continuing Education Council for 1 credit hour. , The ... what sauna, steam, and far-infrared saunas are, where they are frequently installed, and design ...
Breaking Medicine News(10 mins):Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:Amerec’s Steam and Sauna Continuing Education Course Now Approved for Interior Design Credit 2
... ROCKVILLE, Md., Oct. 22 Vanda Pharmaceuticals,Inc. (Nasdaq: ... present five posters on,the pharmacogenetics of iloperidone at ... meeting to be held in San Diego, CA, ... follows the submission of the,NDA filing for iloperidone ...
... peer through a patients skin and see a cancer tumor ... migrate: how they look, how they interact with the blood ... body. , Scientists at the University of California, ... skin. But a small, tropical minnow fish common to ...
... LINTHICUM, Md., Oct. 22 Dialysis Corporation,of America ... will be releasing third,quarter 2007 earnings after the ... Dialysis Corporation of America owns and operates ... Jersey, Ohio,Pennsylvania, South Carolina and Virginia, and provides ...
... Lincare Holdings,Inc. (Nasdaq: LNCR ), a leading ... patients in the home, today announced,financial results for the ... For the quarter ended September 30, 2007, revenues were ... for the third quarter of,2006. The Company estimates that ...
... HOUSTON, Oct. 22, 2007 Wearing a portable ... obesity and its related health consequences may be ... performed at the University of Houston and The ... Miller, director of the High-Temperature Superconducting Device Applications ...
... at HealthyDiningFinder.com helps guests put more sizzle in ... ... Calorie-counting, sodium-,watching and cholesterol-avoiding diners have a new option at, ... online resource, helping diners choose healthful,meals away from home. Sizzler also ...
Cached Medicine News:Health News:Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting 2Health News:Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting 3Health News:Transparent zebrafish help researchers track breast cancer 2Health News:Transparent zebrafish help researchers track breast cancer 3Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results 2Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results 3Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results 4Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results 5Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results 6Health News:Fighting obesity may be as easy as ATP, says UH researcher 2Health News:Fighting obesity may be as easy as ATP, says UH researcher 3Health News:Sizzler Joins Nationwide Healthy Dining Program; Completes Move to Trans Fat- Free Cooking Oil 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: